Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grano

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 14, 2019
A Novel Interplay Between Irisin and PTH: From Basic Studies to Clinical Evidence in HyperparathyroidismAndrea Palermo, Lorenzo Sanesi, Graziana Colaianni, et al.
Journal of Immunology Research|May 23, 2015
Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activityAngela Oranger, Giacomina Brunetti, Claudia Carbone, et al.
Bone|March 8, 2017
Sclerostin stimulates angiogenesis in human endothelial cellsAngela Oranger, Giacomina Brunetti, Graziana Colaianni, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 10, 2013
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatmentGiacomina Brunetti, Maria Felicia Faienza, Laura Piacente, et al.
Journal of Translational Medicine|June 20, 2026
Irisin treatment counteracts bone loss and muscle atrophy in aged mice by reducing sclerostin expression in bone and skeletal muscleClelia Suriano, Roberta Zerlotin, Michela Taurino, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 13, 2026
Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stagesManuela Dicarlo, Patrizia Pignataro, Daniele Urso, et al.
The Journal of Pathology|January 29, 2020
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone lossGiacomina Brunetti, Giuseppina Storlino, Angela Oranger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2013
Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremiaRoberto Tamma, Li Sun, Concetta Cuscito, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled diseaseSilvia Colucci, Giulia Taraboletti, Luca Primo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 29, 2014
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2Marika Sciandra, Maria Teresa Marino, Maria Cristina Manara, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|February 14, 2019
A Novel Interplay Between Irisin and PTH: From Basic Studies to Clinical Evidence in HyperparathyroidismAndrea Palermo, Lorenzo Sanesi, Graziana Colaianni, et al.
Journal of Immunology Research|May 23, 2015
Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activityAngela Oranger, Giacomina Brunetti, Claudia Carbone, et al.
Bone|March 8, 2017
Sclerostin stimulates angiogenesis in human endothelial cellsAngela Oranger, Giacomina Brunetti, Graziana Colaianni, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 10, 2013
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatmentGiacomina Brunetti, Maria Felicia Faienza, Laura Piacente, et al.
Journal of Translational Medicine|June 20, 2026
Irisin treatment counteracts bone loss and muscle atrophy in aged mice by reducing sclerostin expression in bone and skeletal muscleClelia Suriano, Roberta Zerlotin, Michela Taurino, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 13, 2026
Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stagesManuela Dicarlo, Patrizia Pignataro, Daniele Urso, et al.
The Journal of Pathology|January 29, 2020
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone lossGiacomina Brunetti, Giuseppina Storlino, Angela Oranger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2013
Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremiaRoberto Tamma, Li Sun, Concetta Cuscito, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled diseaseSilvia Colucci, Giulia Taraboletti, Luca Primo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 29, 2014
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2Marika Sciandra, Maria Teresa Marino, Maria Cristina Manara, et al.
Pageof 14